Engineering yeast to produce fraxetin from ferulic acid and lignin
Applied Microbiology and Biotechnology · 27.01.2025 · 109 (1)
DOI: 10.1007/s00253-025-13409-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 27.01.2025. Verfasst von Bo-Tao He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering a…. Hauptthemen laut MEDLINE: Coumaric Acids, Lignin, Saccharomyces cerevisiae, Metabolic Engineering. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Tianjin Municipal Science and Technology Program.
Abstract (Originalsprache)
Lignin, the most abundant renewable source of aromatic compounds on earth, remains underexploited in traditional biorefining. Fraxetin, a naturally occurring flavonoid, has garnered considerable attention in the scientific community due to its diverse and potent biological activities such as antimicrobial, anticancer, antioxidant, anti-inflammatory, and neurological protective actions. To enhance the green and value-added utilization of lignin, Saccharomyces cerevisiae was engineered as a cell factory to transform lignin derivatives to produce fraxetin. The expression of scopoletin 8-hydroxylase (S8H) and coumarin synthase (COSY) enabled S. cerevisiae to produce fraxetin from ferulic acid, one of the three principal monomers. The optimized fermentation strategies produced 19.1 mg/L fraxetin from ferulic acid by engineered S. cerevisiae. Additionally, the engineered cell factory achieved a fraxetin titer of 7.7 mg/L in lignin hydrolysate. This study successfully demonstrates the biotransformation of lignin monomers and lignin hydrolysate into fraxetin using a S. cerevisiae cell factory, thereby providing a viable strategy for the valorization of lignin. KEY POINTS: • AtS8H showed substance specificity in the hydroxylation of scopoletin. • AtCOSY and AtS8H were key enzymes for converting ferulic acid into fraxetin. • Yeast was engineered to produce fraxetin from lignin hydrolysate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
- Frontiers Research Institute for Synthetic Biology, Tianjin University, Tianjin, China.
- Frontiers Science Center for Synthetic Biology and Key Laboratory of Systems Bioengineering (Ministry of Education), School of Chemical Engineering and Technology, Tianjin University, Tianjin, China. bzli@tju.edu.cn.
- Frontiers Research Institute for Synthetic Biology, Tianjin University, Tianjin, China. bzli@tju.edu.cn.
Förderung
- Tianjin Municipal Science and Technology Program
Zitieren
APA
He, B. T., & Li, B. Z. (2025). Engineering yeast to produce fraxetin from ferulic acid and lignin. Applied Microbiology and Biotechnology, 109(1). https://doi.org/10.1007/s00253-025-13409-1
Vancouver
He BT, Li BZ. Engineering yeast to produce fraxetin from ferulic acid and lignin. Applied Microbiology and Biotechnology. 2025;109(1). doi:10.1007/s00253-025-13409-1
BibTeX
@article{He2025,
author = {He, Bo-Tao and Li, Bing-Zhi},
title = {Engineering yeast to produce fraxetin from ferulic acid and lignin},
journal = {Applied Microbiology and Biotechnology},
year = {2025},
volume = {109},
number = {1},
doi = {10.1007/s00253-025-13409-1}
}
EUVIMED